Dr Reddy's Lab gets two observations for Andhra plant from USFDA

8 Jul 2022 , 09:19 AM

Dr Reddys Laboratories Ltd has informed that the United States Food & Drug Administration (USFDA) on Thursday completed a Pre-Approval Inspection (PAI) at its formulations manufacturing facility FTO 11 in Srikakulam, Andhra Pradesh.

According to the said filing, the inspection was conducted from June 30, 2022 to July 07, 2022.

“We have been issued a Form 483 with two observations, which we will address within the stipulated timeline”, the company said.

On Friday at around 9:18 AM, Dr Reddys Laboratories was trading at Rs4,348 per share up by Rs9.65 or 0.22% from its previous closing of Rs4,338.35 per share on the BSE.